You are here

oncology

JPM: Biotech, VC execs on where the industry should look beyond cancer

Fierce Biotech

Fri, 01/17/20 - 12:34 pm

Alzheimer's disease

venture capital

Fostering Oncology Product Development for Kids with Cancer

FDA Law Blog

Thu, 01/9/20 - 09:55 am

drug development

Drug developers take fresh aim at 'guided-missile' cancer drugs

Reuters

Mon, 01/6/20 - 10:38 am

drug development

antibody-drug conjugate

The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer

Endpoints

Mon, 01/6/20 - 10:27 am

Black Diamond Therapeutics

I-Mab Biopharma

Amgen to Sell Cancer Drugs in China Thanks to $2.7B Deal with BeiGene

Xtalks

Fri, 01/3/20 - 10:51 pm

Drugmakers rebranding around oncology, rare diseases could provide 2020 preview

Fierce Pharma

Thu, 12/19/19 - 11:32 pm

Takeda Strikes Potential $1 Billion Oncology Deal with Turnstone

BioSpace

Thu, 12/19/19 - 12:56 pm

Turnstone Biologics

All hail drug reps: Most cancer docs rely on pharma salespeople for info, survey finds

Fierce Pharma

Tue, 12/17/19 - 10:47 am

Cardinal Health

When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance

RAPS.org

Thu, 12/12/19 - 05:27 pm

pediatric cancer

Merck to acquire ArQule for $20 per share in cash or about $2.7 billion

Marketwatch

Mon, 12/9/19 - 10:06 am

Why The Obsession With A Universal Cure For Cancer May Be Harming Research And Patients

Forbes

Sun, 12/8/19 - 10:15 pm

universal cancer vaccine

Lilly puts its cancer future in Loxo's hands

Biopharma Dive

Thu, 12/5/19 - 10:20 am

Is Clovis Oncology Really a Buyout Candidate?

Motley Fool

Tue, 12/3/19 - 10:21 pm

Clovis Oncology

Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio

Fierce Pharma

Tue, 12/3/19 - 10:02 am

Teva forms academic R&D pacts to further biopharma strategy

Fierce Biotech

Tue, 11/26/19 - 10:21 am

Teva Pharmaceutical

AstraZeneca CEO: Closing In On A Cancer Cure

Yahoo/Benzinga

Sat, 11/23/19 - 04:20 pm

Radius plans to cut loose oncology assets

Fierce Biotech

Wed, 11/6/19 - 10:13 am

endocrine disorders

Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny

Fierce Pharma

Mon, 11/4/19 - 07:27 pm

Biocept Files for $27 Million Offering

CP Wire

Mon, 11/4/19 - 09:55 am

CMS proposes lifting restrictions on NGS cancer testing

Biopharma Dive

Thu, 10/31/19 - 10:39 am

next generation sequencing

Pages